Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Immunoprecise Antibodies Ltd
IPA
Healthcare
Biotechnology
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem...
Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:IPA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Mar 29, 2022 12:25pm
IPA Announces Agreement to Acquire BioStrand BV – Revolution
Acquisition includes wholly owned subsidiary businesses BioKey BV and BioClue BV. Platform is based on a proprietary biological discovery called HYFT™ patterns, signature sequences in DNA, RNA
...more
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Mar 16, 2022 12:52pm
ImmunoPrecise Reports Financial Results and Recent Business
Third Quarter Fiscal Year 2022 Financial Summary* (All comparisons are to the period ended January 31, 2022) The Company achieved Project revenue of $4.1 million, an increase of $0.7 million or
...more
(1)
•••
Dragon1
X
View Profile
View Bullboard History
Post by
Dragon1
on Mar 16, 2022 9:56am
Good quarter
Increase in the CRO business and lots of cash to finance the research arm,we just have to wait for approval of the vaccin which keeps getting closer.One big annoncement this summer could get us back
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Mar 14, 2022 1:45pm
RE:IPA Selected to Work with Elektrofi on COVID-19 Therapeutic
That is good news. With the markets spooked IPA, in my opinion, is a strong buy.
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Mar 14, 2022 12:26pm
IPA Selected to Work with Elektrofi on COVID-19 Therapeutic
Companies to pursue a low-volume injectable formulation of IPA’s COVID-19 antibody cocktail, PolyTope® TATX-03 The new formulation, TATX-03E, aims to address the patient need for a stable
...more
(1)
•••
Dragon1
X
View Profile
View Bullboard History
Post by
Dragon1
on Mar 14, 2022 9:50am
More good news
New deal with Elektrofi,IPA keeps adding partners and deals related to the polytrope vac which means they all see potential.New variants imply that we will probably be dealing with this virus for a
...more
(1)
•••
Dragon1
X
View Profile
View Bullboard History
Post by
Dragon1
on Mar 10, 2022 9:58am
$4.97
Got a bunch this morning,this is close to a penny stock before the reverse split,really time to BUY!
(1)
•••
Dragon1
X
View Profile
View Bullboard History
Post by
Dragon1
on Mar 09, 2022 1:20pm
Update
The latest on toxicology tests sure didn't have any impact,anybody know why the sp keeps dropping?
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Mar 09, 2022 11:51am
IPA Updates on Investigational New Drug (IND)
As a prelude to a formal toxicology study, a maximum tolerated dose and a pharmacokinetic study were completed using injections of up to 12.5 times the anticipated highest dose proposed for the phase
...more
(1)
•••
Dragon1
X
View Profile
View Bullboard History
Post by
Dragon1
on Mar 08, 2022 2:10pm
Financials
Hopefully we will get numbers a bit better than the last quarter if the CRO business performs well this should maintain cash flow and sp price until the research arm starts generating revenue. There
...more
(2)
•••
AveragePenny
X
View Profile
View Bullboard History
Post by
AveragePenny
on Mar 08, 2022 11:28am
ImmunoPrecise Sets Third Quarter Fiscal 2022 Financial
Investors interested in submitting questions ahead of the call are encouraged to email John Mullaly of LifeSci Advisors, the Company’s investor relations contact. Earnings Call Details: Date:
...more
(2377)
•••
dart321
X
View Profile
View Bullboard History
Post by
dart321
on Feb 15, 2022 12:53pm
MLCL
Look at it quick boys!!!!
(742)
•••
mercedesman
X
View Profile
View Bullboard History
Post by
mercedesman
on Feb 04, 2022 3:41pm
Are we there yet?
Just checking in to see how my lottery ticket is doing ? the beauty of it is, if I don't win the lottery with IPA, then I can trade my spent ticket for and already well perfoming CRO business as
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Feb 01, 2022 12:19pm
RE:Key words...
This is awesome news. Hopefully leads to fast tracked trials. Can you imagine if this works they can do the same for the flu and the common cold. This is nuclear because there are no respiratory
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Growth Rocket 2025 – Why dynaCERT is in the Spotlight
Do you want to stay ahead of the markets? See how DealRoom can help.